Charles River Opens CRADL® Philadelphia to Support Research and Discovery


Charles River Laboratories, a leading drug discovery and non-clinical development company, will open a new Charles River Accelerator and Development Lab (CRADL®) location in Philadelphia’s One uCity Square in October 2023. The company’s expansion will provide research support to the region’s life sciences community to facilitate their early drug discovery and preclinical in vivo research.

CRADL® Philadelphia’s grand opening will be held from 4:00-6:00 p.m. on Wednesday, October 18, 2023, at One uCity Square. Charles River is inviting researchers in biotech, academia, and pharma, and the professionals, incubators, and organizations who support their progress to tour the […]

Award-Winning Biotech Training Program to Begin Second Recruitment

The Wistar Institute, the West Philadelphia Skills Initiative, Iovance Biotherapeutics, PIDC, and The Chamber of Commerce for Greater Philadelphia Launch Second Recruitment for the Award-Winning Program on August 22, 2023.

Partners in Greater Philadelphia’s life sciences ecosystem are expanding their commitment to connecting a wider range of Philadelphians, including residents from disadvantaged communities, with career opportunities in the burgeoning biotech industry with the announcement of upcoming recruitment for an award-winning biotech training program.

The launch of recruitment for the second cohort of The “Biomedical Technician Training Program: Aseptic Manufacturing” follows on the heels of the successful implementation of a pilot program that […]

AmerisourceBergen’s New Integration Hub Streamlines the Path-to-Care Process for Cell and Gene Therapy Innovators

Cell and gene therapy developers worldwide have a new source of support in positioning their therapies for success thanks to the launch of the Cell and Gene Therapy (CGT) Integration Hub by Greater Philadelphia-based Chamber member AmerisourceBergen. The global pharmaceutical solutions company, headquartered in Conshohocken, Pa., announced its CGT Integration Hub on April 24, 2023. The platform-agnostic system, powered by the company’s customer relationship management system, aims to improve connectivity across the cell and gene therapy treatment journey by streamlining the path-to-care process to enable an enhanced patient and provider experience.

Specifically, AmerisourceBergen’s CGT Integration […]

Greater Philadelphia Continues to Launch Innovative Workforce Solutions

Last August, the Chamber was pleased to partner with the West Philadelphia Skills Initiative (WPSI), The Wistar Institute, PIDC, and Philadelphia Works on a pilot project to offer innovative workforce solutions for the region’s life sciences industry. Together the collaborators launched a first-of-its-kind Biomedical Technician Training Program: Aseptic Manufacturing, with Iovance Biotherapeutics, Inc., a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, as the program’s first employer partner. The program’s successful design and implementation have led to a second cohort – an innovative workforce […]

Chamber to Share Region’s Life Sciences Story at BIO 2023

It was four years ago, at the 2019 BIO International Convention held in Philadelphia, that the Chamber of Commerce for Greater Philadelphia launched the region’s Cell & Gene Therapy and Connected Health Initiative to further boost the market as a leading center for life sciences and a top cell and gene therapy, gene editing, and connected health technology hub. The global attendees at the convention, representing biotech leaders from more than 30 countries, were the ideal audience to hear the news of the region’s expertise and expansion efforts in these industries.

Since 2019, the region’s rapidly expanding life sciences industry has […]

Women Lead Life Sciences Job Growth in Region

As the number of life sciences jobs in the Greater Philadelphia region grows, an increasing number of those jobs are being held by women, according to data the Chamber of Commerce for Greater Philadelphia analyzed from Lightcast, a global labor market data and analytics company. Over the past decade, Philadelphia has seen a 12% increase in women working in life sciences occupations compared  to 8.6% growth for men (Lightcast’s Historical Demographics by Occupation, 2023), including growth in cell and gene therapy roles. The uptick is reflected across professions, including biochemists and biophysicists, medical scientists, biological scientists, and biological technicians.

Lightcast also […]

Penn Center for Innovation Report Highlights Record-Breaking Commercialization Activity

In the center of Philadelphia, on the campus of the University of Pennsylvania, sits an institution that enhances Greater Philadelphia’s growing reputation for scientific and technological innovation. At the Penn Center for Innovation (PCI), Penn’s inventors are connected with the resources they need to translate discoveries into products and businesses that can have a societal impact. Penn faculty members and researchers, companies seeking strategic alliances, entrepreneurs, and many other types of Penn innovators – PCI serves them all, as it works to bring promising technologies and start-up ideas to light. In its recent PCI […]

ChristianaCare Spins Out CorriXR Therapeutics

On October 11, 2022, Wilmington, Delaware-based ChristianaCare announced it had spun out its first commercial biotechnology private startup company, CorriXR Therapeutics. The startup will use CRISPR gene editing technology to develop new, clinically relevant oncologic therapeutics in areas of unmet medical need, starting with squamous cell carcinoma of the lung.

CorriXR Therapeutics’ close relationship with ChristianaCare and the ChristianaCare Gene Editing Institute uniquely positions the new company to research and develop innovative, patient-centered therapies, the nonprofit health system said in its release. CorriXR Therapeutics will license technology from the Gene Editing Institute and work closely with its […]

Life Sciences PA Shares Industry Impact Report

Our region’s life sciences ecosystem has three new assets we can all use to amplify the discovery, talent, and momentum in Greater Philadelphia. The first is a study by Econsult ranking Greater Philadelphia #2 in cell and gene therapy compared with 14 U.S. cell and gene therapy clusters. You can read about the research and link to the report here; it was recently featured in the trade publication Cell & Gene. The second is JLL’s  2022 Life Sciences Research Outlook & Cluster Rankings, in […]

Comparative Study Ranks Philadelphia Region #2 Among 14 Cell and Gene Therapy Hubs

In a newly released study comparing 14 U.S. cell and gene therapy hubs in five key categories, the Philadelphia region ranks #2 among U.S. locations. Commissioned by the Chamber of Commerce for Greater Philadelphia and researched by economic consulting firm Econsult Solutions, Inc. (ESI), the study compares cell and gene therapy hubs in research infrastructure, human capital, innovation output, commercial activity, and value proposition. The only region ranked higher overall than Philadelphia was Boston. New York and San Francisco were ranked #3 and #4, respectively.

“The Philadelphia region is increasingly attracting new […]

Go to Top